Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

29.6%

147 terminated/withdrawn out of 496 trials

Success Rate

64.8%

-21.8% vs industry average

Late-Stage Pipeline

3%

14 trials in Phase 3/4

Results Transparency

35%

96 of 271 completed trials have results

Key Signals

46 recruiting96 with results69 terminated78 withdrawn

Enrollment Performance

Analytics

N/A
183(42.0%)
Phase 2
133(30.5%)
Phase 1
80(18.3%)
Early Phase 1
26(6.0%)
Phase 3
12(2.8%)
Phase 4
2(0.5%)
436Total
N/A(183)
Phase 2(133)
Phase 1(80)
Early Phase 1(26)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (496)

Showing 20 of 496 trials
NCT06738303Phase 2Recruiting

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

Role: lead

NCT06262516Not ApplicableRecruiting

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Role: lead

NCT07079098Phase 1Recruiting

Trial of Oligometastasis SBRT With Immediate, Simulation-Free Treatment Delivery (OLIGO-SWIFT)

Role: lead

NCT06649201Recruiting

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

Role: lead

NCT07719127Phase 1Not Yet Recruiting

Study of Disulfiram to Reduce Myeloid Immunosuppression and Steroid Dependence in Resectable High Grade Glioma

Role: lead

NCT06084780Phase 2Not Yet Recruiting

Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)

Role: lead

NCT06290687Phase 2Withdrawn

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Role: lead

NCT07834281Phase 4Not Yet Recruiting

High-concentration Capsaicin Patch for the Prevention of Paclitaxel-induced Peripheral Neuropathy

Role: lead

NCT07060261Not ApplicableRecruiting

Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma

Role: lead

NCT07117032Phase 1Recruiting

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain

Role: lead

NCT07104630Phase 2Recruiting

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Role: lead

NCT07146646Phase 2Recruiting

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Role: lead

NCT07735611Not ApplicableNot Yet Recruiting

Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)

Role: lead

NCT07248228Phase 2Recruiting

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

Role: lead

NCT04556045Not ApplicableCompleted

Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer

Role: lead

NCT03277638Phase 1Completed

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Role: lead

NCT03535350Phase 1Active Not Recruiting

Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Role: lead

NCT06263088Not ApplicableRecruiting

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Role: lead

NCT07044362Not ApplicableRecruiting

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

Role: lead

NCT06129760Not ApplicableSuspended

Glioblastoma Remote Monitoring and Care - Research Protocol

Role: lead